<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01358279</url>
  </required_header>
  <id_info>
    <org_study_id>2009-4615-A</org_study_id>
    <nct_id>NCT01358279</nct_id>
  </id_info>
  <brief_title>Transcranial Direct Current Stimulation for Migraine Attack</brief_title>
  <official_title>Manho Kim, MD, PhD Professor, Neurology Seoul National University Hospital,</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <brief_summary>
    <textblock>
      This study is conducted to investigate the therapeutic efficacy and safety of transcranial&#xD;
      direct current stimulation (tDCS) over the primary motor cortex of patients with acute&#xD;
      migraine attack.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants who experienced pain relief of one level or more</measure>
    <time_frame>at 2h post-treatment</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Acute Migraine</condition>
  <arm_group>
    <arm_group_label>migraine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>transcranial direct current stimulation</intervention_name>
    <description>A constant current of 2 mA intensity applied for 20 min over C3 or C4</description>
    <arm_group_label>migraine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged 17-70 years&#xD;
&#xD;
          -  Migraine&#xD;
&#xD;
               -  With or without aura&#xD;
&#xD;
               -  The first attack of migraine was earlier than 50 years of age&#xD;
&#xD;
               -  One to 8 moderate to severe migraine attacks per month in the 2 months preceding&#xD;
                  the screening&#xD;
&#xD;
          -  Willing and able to give written informed consent&#xD;
&#xD;
          -  Able to read, comprehend and complete the diary form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Not able to distinguish between migraine and non-migraine headache&#xD;
&#xD;
          -  Combined headache, including the tension type headache and medication overuse headache&#xD;
&#xD;
          -  Pregnant, actively trying to become pregnant or breast-feeding women&#xD;
&#xD;
          -  Uncontrolled and significant medical illness&#xD;
&#xD;
          -  Vertebrobasilar or hemiplegic migraine according to the International Headache Society&#xD;
             diagnostic criteria&#xD;
&#xD;
          -  Having intracranial metal implants or a cardiac pacemaker&#xD;
&#xD;
          -  A history of epilepsy or other organic brain disorders&#xD;
&#xD;
          -  A history of psychological diseases&#xD;
&#xD;
          -  Having changed medications for migraine within 1 month before giving us informed&#xD;
             consent&#xD;
&#xD;
          -  Drug abuser or alcoholics&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <study_first_submitted>May 18, 2011</study_first_submitted>
  <study_first_submitted_qc>May 20, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 23, 2011</study_first_posted>
  <last_update_submitted>October 23, 2016</last_update_submitted>
  <last_update_submitted_qc>October 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Manho Kim</investigator_full_name>
    <investigator_title>Manho Kim, MD, PhD Professor, Neurology Seoul National University Hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

